The Challenge of Treating Biofilm‐associated Bacterial Infections

By J. L. Pozo, R. Patel. Clinical pharmacology and therapy, 2007

653 citations recorded by the source corpus.

Subfields: Molecular Biology, Molecular Medicine, Periodontics

View Paper: https://www.semanticscholar.org/paper/02aeafeffc6d7be0b2d284dcdae0138fd7936067

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. A. Horswill
2. Matthew J. Thoendel
3. Aleeza J. Roth
4. Blaise R. Boles
5. Shriti Singh
6. S. Singh
7. I. Chowdhury
8. Robin Patel

In Molecular Medicine

1. Shriti Singh
2. S. Singh
3. I. Chowdhury
4. Robin Patel
5. Rajesh Singh
6. A. Horswill
7. Blaise R. Boles

In Periodontics

1. Robin Patel
2. A. Horswill
3. Blaise R. Boles

Citations in the corpus

• Identification of Genes Involved in Polysaccharide-Independent Staphylococcus aureus Biofilm Formation (2010, background): “The most notorious biofilm characteristic is their extraordinary resistance to antimicrobial killing [4].”
• Ciprofloxacin Causes Persister Formation by Inducing the TisB toxin in Escherichia coli (2010, neutral): “biofilm infections [1,2].”
• Understanding the Mechanism of Bacterial Biofilms Resistance to Antimicrobial Agents (2017, background): “Stationary phase bacteria produced a high level of persister cells and correlated with the increasing resistance inside biofilm [30].”
• Prosthetic Joint Infection (2014, background): “The reduced antimicrobial susceptibility of bacteria in biofilms is related to their low growth rate, the presence of resistant bacterial subpopulations (so-called “persisters”), and a microenvironment within the biofilm that impairs antimicrobial activity (85, 86).”